From academic research to patented technologies, NeckEpur transforms scientific breakthroughs into real-world impact.
Built on five years of research at AP-HP, one of Europe's leading hospital groups.
Protected by international patents, ensuring unique and reliable solutions.
Advanced AI for predictive modeling, detection and real-time analysis.
Next-generation active filters designed to capture ultra-trace contaminants.
NeckEpur SAS is an impact-driven deep-tech company combining artificial intelligence, patented technologies and active filtration systems to detect and measure ulta-trace contaminants.
Originally spun out from Assistance Publique-Hôpitaux de Paris (AP-HP), NeckEpur builds on more than five years of academic research dedicated to understanding interactions between drugs and Medical Devices in Extracoporeal Circulation (MDEC).
Our mission is to transform advanced scientific discoveries into practical solutions that improve patient care, support healthcare professionals, and address emerging environmental challenges.
All NeckEpur developments are built upon of patented technologies encompassing proprietary methods, AI-powered software solutions, and next-generation filtration systems.
These innovations provide the scientific foundation for broad rangee of applications designed to anticipate, assess, and solve complex molecule-materiel interaction challenges.
Protected IP
and proprietary methods
AI-powered prediction
of molecule-material interactions
Selective removal
of targeted contaminants
Integrated solutions to understand, predict, and remove harmful interactions for better health and a cleaner environment.
Expert services
Leveraging our proprietary in silico assessment methodology, we support pharmaceutical companies, medical device manufacturers and healthcare stakeholders in evaluating and mitigating drug sequestration risks.
AI-Powered
SaaS Platform
Assess drug sequestration phenomena
Predict molecule-membrane interactions in real time
Support molecule and filtration membrane design optimization
Advanced Filtration Techno-logies
We develop active filtration solutions capable of selectively removing harmful contaminants from blood and water systems.
A structured pathway transforming scientific
innovation into validated clinical and industrial impact.
Validate mechanims and demonstrat scientific proof of concept.
Develop and optimize our technologies and prototypes.
Generate preclinical data and engage with regulatory authorities.
Scale-up manufacturing and validate performance in relevant environments.
Prepare for clinical or industrial use and market introduction.
Transforming scientific breakthroughs into validated solutions addressing critical healthcare and environmental challenges.